Sexual Dysfunction, Physiological
Conditions
Brief summary
The Pfizer developed Heat Wash-Out (HWO) system is a software controlled electromechanical system designed to measure vaginal wall blood flow. A small vaginal probe is attached to a control unit. Output data is collected on a PC. By measuring the clearance of heat from the heated probe, a direct measure of absolute blood flow can be obtained. The study will assess changes in vaginal blood flow across the menstrual cycle following visual sexual stimulation.
Detailed description
Medical Device Development
Interventions
No drug administered. Device tested three times with each subject.
Sponsors
Study design
Eligibility
Inclusion criteria
* Pre-menopausal healthy women aged 18-45 with regular, natural menstrual cycles. * Subjects must be void of Female Sexual Disorder.
Exclusion criteria
* Pregnant or lactating women * Postmenopausal subjects * Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric or neurologic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate differences in vaginal blood flow across the menstrual cycle following visual sexual stimulation. | 28d |
| To assess the safety and toleration of the heat washout device. | 28d |
Secondary
| Measure | Time frame |
|---|---|
| To investigate changes in subjective acute sexual arousal following visual sexual stimulation across the menstrual cycle. | 28d |
Countries
Australia